Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Gottschalk

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
Cytotherapy|May 24, 2012
Interleukin-13 receptor α2: glioma's unlucky receptor?Stephen Gottschalk
Haematologica|December 7, 2022
Terrific cells for SARS-CoV-2Stephen Gottschalk
Cytotherapy|May 5, 2011
TILling head and neck cancer for cell therapyStephen Gottschalk
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Clinical and virological characteristics of patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation: insights and questionsStephen Gottschalk
Expert Review of Vaccines|April 29, 2009
How to design effective vaccines: lessons from an old success storyNabil Ahmed, Stephen Gottschalk
Science (New York, N.Y.)|June 19, 2025
Engineering immunotherapy from withinVivek Peche, Stephen Gottschalk
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CAR T cells for solid tumors: armed and ready to go?Sunitha Kakarla, Stephen Gottschalk
Advances in Experimental Medicine and Biology|June 14, 2014
Genetically modified T-cell therapy for osteosarcomaChristopher DeRenzo, Stephen Gottschalk
Med (New York, N.Y.)|June 11, 2022
CAR T cell therapy for solid tumors: Fatal attraction requires adhesionMatthew Bell, Stephen Gottschalk
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2016
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human CancersMelinda Mata, Stephen Gottschalk
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
Cytotherapy|May 24, 2012
Interleukin-13 receptor α2: glioma's unlucky receptor?Stephen Gottschalk
Haematologica|December 7, 2022
Terrific cells for SARS-CoV-2Stephen Gottschalk
Cytotherapy|May 5, 2011
TILling head and neck cancer for cell therapyStephen Gottschalk
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Clinical and virological characteristics of patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation: insights and questionsStephen Gottschalk
Expert Review of Vaccines|April 29, 2009
How to design effective vaccines: lessons from an old success storyNabil Ahmed, Stephen Gottschalk
Science (New York, N.Y.)|June 19, 2025
Engineering immunotherapy from withinVivek Peche, Stephen Gottschalk
Cancer Journal (Sudbury, Mass.)|March 27, 2014
CAR T cells for solid tumors: armed and ready to go?Sunitha Kakarla, Stephen Gottschalk
Advances in Experimental Medicine and Biology|June 14, 2014
Genetically modified T-cell therapy for osteosarcomaChristopher DeRenzo, Stephen Gottschalk
Med (New York, N.Y.)|June 11, 2022
CAR T cell therapy for solid tumors: Fatal attraction requires adhesionMatthew Bell, Stephen Gottschalk
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 1, 2016
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human CancersMelinda Mata, Stephen Gottschalk
Pageof 23